J&J’s OTC business reports double-digit growth

27 January 2022 - Deborah Wilkes

Premium

Johnson & Johnson (J&J) reported double-digit sales growth at its OTC business in the fourth quarter of 2021 and released additional information on the planned separation of its Consumer Health division.

Click tags below for more information on topics:

Johnson & Johnson

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: